Martinsried/Munich, July 23, 2010. MediGene AG (Frankfurt, Prime Standard, MDG, TecDAX) announces that for organisational reasons the publication of the 6-month 2010 financial report has been rescheduled to Thursday, August 5, 2010 (previously: Friday, August 6, 2010).
An analyst conference call and webcast in English will take place at 10:00 am CET on Thursday, August 5, 2010. Access to the webcast including synchronized slides will be possible at the MediGene website at www.medigene.com. A replay will also be available thereafter.
- ends -
MediGene AG is a publicly listed (Frankfurt, Prime Standard: MDG, TecDAX) biotechnology company located in Martinsried/Munich, Germany, with subsidiaries in Oxford, UK and San Diego, USA. MediGene is the first German biotech company to have drugs on the market which are distributed by partner companies. It has several drug candidates in clinical development and possesses innovative platform technologies. MediGene focuses on clinical research and development of novel drugs with focus on oncology.
Contact MediGene AG
Fax: ++49 - 89 - 85 65 - 2920
Julia Hofmann / Dr. Nadja Wolf, Public Relations, Tel.: ++49 - 89 - 85 65 - 3324
Dr. Georg Dönges, Investor Relations, Tel.: ++49 - 89 - 85 65 - 2946